Bits of technology from I.B.M.’s Watson are beginning to be used in actual products available to corporate clients. The cloud-based Strategic Intellectual Property Insight Platform “uses data mining, natural-language processing and analytics to pore through millions of patent filings and biomedical journals to look for chemical compounds used in drug discovery.” As a byproduct of this project, I.B.M. is contributing their research to the searchable NIH chemical database, which will ease access to information previously mired in paperwork.
Subscribe to our e-newsletterVIEW OUR CURRENT ISSUE >
Tagsbiofuels health healthcare climate change Benefits of biotech crops BIOTECH BIO Investor Forum Sustainability BIO International Convention Food Partnering Health Care Industry Analysis biotechnology BIO Events Plant biotechnology Biotechnology Industry 2014 BIO International Convention BIO global food crisis
- Most Popular
Latest VideoLooking Forward to BIO 2015 View All >